In the months between February 2014 and August 2016, gene
editing was featured on the covers of Time, The Economist, National
Geographic, and the MIT Technology Review. As awareness of the
technologies has grown, expectations have risen. Investors are
seeing validation for their early bets and the general public has begun
to anticipate a series of near term and profound breakthroughs.

In this white paper, we identify nine aspects of the emerging gene
editing market that should be considered by life sciences strategy
teams tasked with anticipating the impact that rapid development
of gene editing techniques will have on their companies’ businesses.